Sheffali Gulati
Medical and Health Sciences / Pediatric Neurology
AD Scientific Index ID: 5012383
अखिल भारतीय आयुर्विज्ञान संस्थान
PROJECTS
| Subject | Title | Source Of Funding | Budget | Start Date | End Date |
|---|---|---|---|---|---|
| “A study on development of “Epilepsy care App” and assess its utility and satisfaction among parents of children with Epilepsy reporting at AIIMS, New Delhi” (IRG) | “A study on development of “Epilepsy care App” and assess its utility and satisfaction among parents of children with Epilepsy reporting at AIIMS, New Delhi” (IRG) | Govt Agency | 2,25,000/- | - | - |
| To study the prevalence of Celiac disease and non-celiac gluten-related disorders in children with ASD | To study the prevalence of Celiac disease and non-celiac gluten-related disorders in children with ASD | Govt Agency | 1,76,000/- | - | - |
| Host inflammatory response and its correlation with paradoxical worsening in childhood tubercular meningitis. | Host inflammatory response and its correlation with paradoxical worsening in childhood tubercular meningitis. | 8,75,000/- | - | - | |
| Multimodal evaluation of neural network and neuroinflammatory nexus of electrical status epilepticus in sleep (ESES) in children. | Multimodal evaluation of neural network and neuroinflammatory nexus of electrical status epilepticus in sleep (ESES) in children. | 10,00,000/- | - | - | |
| Association of serum antiseizure medication levels with behavior and cognition in children and adolescent aged 7 – 17 years with pharmaco-responsive non-lesional epilepsy: An observational study. | Association of serum antiseizure medication levels with behavior and cognition in children and adolescent aged 7 – 17 years with pharmaco-responsive non-lesional epilepsy: An observational study. | Govt Agency | 2,00,000/- | - | - |
| Differentiation monophasic and recurrent acquired demyelinating disorders of childhood and adolescence: an HLA typing, serum and CSF inflammatory biomarker based longitudinal observational study. | Differentiation monophasic and recurrent acquired demyelinating disorders of childhood and adolescence: an HLA typing, serum and CSF inflammatory biomarker based longitudinal observational study. | Govt Agency | 10,00,000/- | - | - |
| To compare efficacy and safety of melatonin and triclofos in inducing sleep in children posted for sleep as deprived sleep EEG: a double blind, parallel design, randomized clinical trials (CTRI/2020/02/023592) | To compare efficacy and safety of melatonin and triclofos in inducing sleep in children posted for sleep as deprived sleep EEG: a double blind, parallel design, randomized clinical trials (CTRI/2020/02/023592) | Undergraduate Research Mentorship Scheme, AIIMS, New Delhi | 1,10,000/- | - | - |
| Serum sICAM5 and MP9/TIMP1 Ratio: potential predictors of disease activity in children with encephalopathy with electrical status in sleep (ESES) syndrome. | Serum sICAM5 and MP9/TIMP1 Ratio: potential predictors of disease activity in children with encephalopathy with electrical status in sleep (ESES) syndrome. | Institute Research Grant, AIIMS, New Delhi | 5,00,000/- | - | - |
| Serum matrix metalloproteinase – 9 a potential biomarker for predicting calcification and epilepsy in neurocysticercosis; a longitudinal observational study. | Serum matrix metalloproteinase – 9 a potential biomarker for predicting calcification and epilepsy in neurocysticercosis; a longitudinal observational study. | Institute Research Grant, AIIMS, New Delhi | 5,00,000/- | - | - |
| Exploring the effect of incentive spirometry on pulmonary function and quality of life in 5 to 18 years old patients of DMD on oral steroids for at least 6 months. | Exploring the effect of incentive spirometry on pulmonary function and quality of life in 5 to 18 years old patients of DMD on oral steroids for at least 6 months. | Govt Agency | 2,00,000/- | - | - |
| A multimodality assessment of brain metabolism, microstructural organization and neuroinflammation in subacute sclerosing panencephalitis: a cross-sectional observational study. | A multimodality assessment of brain metabolism, microstructural organization and neuroinflammation in subacute sclerosing panencephalitis: a cross-sectional observational study. | Govt Agency | 2,00,000/- | - | - |
| Mobile App based Augmentative and alternative communication-based intervention in children with ASD. | Mobile App based Augmentative and alternative communication-based intervention in children with ASD. | Govt Agency | 2,00,000/- | - | - |
| Randomized Placebo Controlled Trial of Valproate and Levocarnitine in Children with SMA aged 2 – 15 Years. | Randomized Placebo Controlled Trial of Valproate and Levocarnitine in Children with SMA aged 2 – 15 Years. | Govt Agency | 5,00,000/- | - | - |
| To determine the clinical and neuroimaging characteristics and outcomes of febrile infection related epilepsy syndrome (FIRES) in children. | To determine the clinical and neuroimaging characteristics and outcomes of febrile infection related epilepsy syndrome (FIRES) in children. | Govt Agency | 5,00,000/- | - | - |
| Development of a Bi-lingual Mobile-App based Neuro-Cognitive Screening Tool for Early Identification of Children aged 3-11 years with Autism and ASD co-morbid with ADHD | Development of a Bi-lingual Mobile-App based Neuro-Cognitive Screening Tool for Early Identification of Children aged 3-11 years with Autism and ASD co-morbid with ADHD | Govt Agency | - | - | |
| Air Pollution impact on Pregnancy and Early childhood Development in India - (APiPED Cohort)" | Air Pollution impact on Pregnancy and Early childhood Development in India - (APiPED Cohort)" | Govt Agency | - | - | |
| Molecular characterization and development of immunological based diagnostics for Naegleria fowleri | Molecular characterization and development of immunological based diagnostics for Naegleria fowleri | - | - | ||
| Center for research in “Difficult to treat epilepsy | Center for research in “Difficult to treat epilepsy | Govt Agency | - | - | |
| Capacity Building For Health Care Workers Inpost-Covid Healthcare Systems Of LMICS | Capacity Building For Health Care Workers Inpost-Covid Healthcare Systems Of LMICS | Govt Agency | 4,27,000/- | - | - |
| Financial advocacy in rare (FAIR) patient impact grants to fund impactful programs in rare disease communities | Financial advocacy in rare (FAIR) patient impact grants to fund impactful programs in rare disease communities | Private Agency | $5000 | - | - |
| To Investigate the Role of human Mesenchymal Stem Cell Derived Exosomes as a Cell Free Therapeutic Approach for amelioration of symptoms of Autism Spectrum Disorders (ASD) | To Investigate the Role of human Mesenchymal Stem Cell Derived Exosomes as a Cell Free Therapeutic Approach for amelioration of symptoms of Autism Spectrum Disorders (ASD) | Govt Agency | 74,67,999/- | - | - |
| Clinical and physiological basis of vocalization deficits and motor stereotypies(repetitive and restrictive behaviours in autism spectrum disorder (ASD) | Clinical and physiological basis of vocalization deficits and motor stereotypies(repetitive and restrictive behaviours in autism spectrum disorder (ASD) | Govt Agency | 18,50,000/- | - | - |
| Intermediate and long-term therapeutic efficacy of rTMS in drug refractory focal epilepsy of childhood: A randomized sham-controlled study | Intermediate and long-term therapeutic efficacy of rTMS in drug refractory focal epilepsy of childhood: A randomized sham-controlled study | Govt Agency | 48,00,000/- | - | - |
| A phase III multicenter randomized double blind double dummy study to evaluate safety and efficacy of ocrelizumab in comparison with fingolimod in children and adolescent with relaxing and remitting multiple sclerosis. | A phase III multicenter randomized double blind double dummy study to evaluate safety and efficacy of ocrelizumab in comparison with fingolimod in children and adolescent with relaxing and remitting multiple sclerosis. | Private Agency | 98,46,037/- | - | - |
| Scalable Transdiagnostic Early Assessment of Mental Health (STREAM) | Scalable Transdiagnostic Early Assessment of Mental Health (STREAM) | Govt Agency | - | - | |
| Rapid Assisstive Technology Access (rATA) India 2021 | Rapid Assisstive Technology Access (rATA) India 2021 | Govt Agency | 58632 USD | - | - |
| Role of Artificial Intelligence (AI) in Autism Spectrum Disorder. | Role of Artificial Intelligence (AI) in Autism Spectrum Disorder. | Govt Agency | 40,00,000/- | - | - |
| Empowering children with ASD through the training of Master Trainer. | Empowering children with ASD through the training of Master Trainer. | Govt Agency | 14,29,890/- | - | - |
| Neurocomputing and cognitive intelligence | Neurocomputing and cognitive intelligence | Govt Agency | 2,31,000/- | - | - |
| Developing models based on biomarker signature and clinic-electroencephalographic parameters to predict severity and outcome in pediatric status epilepticus: a longitudinal observational study | Developing models based on biomarker signature and clinic-electroencephalographic parameters to predict severity and outcome in pediatric status epilepticus: a longitudinal observational study | Govt Agency | 53.9 Lakhs | - | - |
| Neurodevelopmental outcomes in infants undergoing surgery for congenital heart defects – A prospective multicenter cohort study | Neurodevelopmental outcomes in infants undergoing surgery for congenital heart defects – A prospective multicenter cohort study | Govt Agency | 22, 85, 050/- | - | - |
| A randomized, double-blind placebo controlled six-month study to evaluate the efficacy, safety and tolerability of Sarizotan in patients with the Rett Syndrome with respiratory symptoms. | A randomized, double-blind placebo controlled six-month study to evaluate the efficacy, safety and tolerability of Sarizotan in patients with the Rett Syndrome with respiratory symptoms. | Private Agency | 72,00,000/- | - | - |
| Development & validation of a scalable mobile platform for screening of developmental neuropsychiatric disorders in low-resource settings: START screening tools for Autism Risk using technology. | Development & validation of a scalable mobile platform for screening of developmental neuropsychiatric disorders in low-resource settings: START screening tools for Autism Risk using technology. | Private Agency | 4,80,480/- | - | - |
| Blood heavy metal levels and quantitative EEG correlates in children with autism | Blood heavy metal levels and quantitative EEG correlates in children with autism | Govt Agency | 49,04,232/- | - | - |
| Long-term Follow-up of Patients with Spinal Muscular Atrophy Treated with OAV101 IT or OAV101 IV in Clinical Trials. | Long-term Follow-up of Patients with Spinal Muscular Atrophy Treated with OAV101 IT or OAV101 IV in Clinical Trials. | Private Agency | 8,89,900/- | - | - |
| Holding hand in magical years – Early childhood development & neurorehabilitation center. | Holding hand in magical years – Early childhood development & neurorehabilitation center. | NGO | 2,31,53,428/- | - | - |
| Developmental screening of children in primary health care settings and establishing referral pathways to early intervention services. | Developmental screening of children in primary health care settings and establishing referral pathways to early intervention services. | Govt Agency | 19,97,940/- | - | - |
| A Brain Machine Interface enabled Biomedical Assistive Communication System for severely motor disabled | A Brain Machine Interface enabled Biomedical Assistive Communication System for severely motor disabled | Govt Agency | 53,72 lacs | - | - |
| To explore the association of Molecular, Genetic and Environmental markers in autism spectrum disorder and other Neurodevelopmental Disorders including ADHD and Cerebral Palsy: A Cross-sectional study | To explore the association of Molecular, Genetic and Environmental markers in autism spectrum disorder and other Neurodevelopmental Disorders including ADHD and Cerebral Palsy: A Cross-sectional study | Govt Agency | 1.38 cr | - | - |
| Enrichment through demonstration and sensitization of paramedics, teachers and students towards children with neurological/neurodevelopmental disorders using multimodal approach and evaluating KAP levels at pre and post intervention | Enrichment through demonstration and sensitization of paramedics, teachers and students towards children with neurological/neurodevelopmental disorders using multimodal approach and evaluating KAP levels at pre and post intervention | Govt Agency | 31,15,152/- | - | - |
| Neurodevelopmental outcomes in infants undergoing surgery for congenital heart defects-A prospective multi-center cohort study. | Neurodevelopmental outcomes in infants undergoing surgery for congenital heart defects-A prospective multi-center cohort study. | Govt Agency | 2,28,505/- | - | - |
| Neuromodulation of cortical excitability and plasticity by low frequency repetitive Transcranial magnetic stimulation in infantile hemiplegic cerebral palsy patients | Neuromodulation of cortical excitability and plasticity by low frequency repetitive Transcranial magnetic stimulation in infantile hemiplegic cerebral palsy patients | Govt Agency | 46,53,130/- | - | - |
| A Double Blind, Placebo-Controlled, Multicentre Study with an Open-Label Extension to Evaluate the Effecacy and Safety of 2’O Methyl Antisense Oligonucleotide in Patients with Duchenne Muscular Dystropy | A Double Blind, Placebo-Controlled, Multicentre Study with an Open-Label Extension to Evaluate the Effecacy and Safety of 2’O Methyl Antisense Oligonucleotide in Patients with Duchenne Muscular Dystropy | Private Agency | 20,00,000/- | - | - |
| A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patient 6 to 17 Years of Age with Episodic Migraine- the REBUILD-1 Study | A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patient 6 to 17 Years of Age with Episodic Migraine- the REBUILD-1 Study | Private Agency | 21,39,160/- | - | - |
| Pediatrics Options for Migrane Relief: A Randomized, Double-Blind, Placebo- Controlled Study of Lasmiditan for Acute Treatment of Migraine:PIONEER PEDS1 | Pediatrics Options for Migrane Relief: A Randomized, Double-Blind, Placebo- Controlled Study of Lasmiditan for Acute Treatment of Migraine:PIONEER PEDS1 | Private Agency | 16,90,880/- | - | - |
| A Phase 3, 12-Month, Open Label Study of Lasmiditan in Pediatric Patients with Migraine-PIONEER-PEDS2 | A Phase 3, 12-Month, Open Label Study of Lasmiditan in Pediatric Patients with Migraine-PIONEER-PEDS2 | Private Agency | 12,17,200/- | - | - |
| A Multicentric Cross-sectional Study of Leukodystrophies in India: A Pilot Project | A Multicentric Cross-sectional Study of Leukodystrophies in India: A Pilot Project | Govt Agency | 5,00,000/- | - | - |
| To evaluate the feasibility of multigene panel for diagnosis and management of autism spectrum disorder in early neonatal period (< 7days) | To evaluate the feasibility of multigene panel for diagnosis and management of autism spectrum disorder in early neonatal period (< 7days) | Govt Agency | 2.85 cr | - | - |
| Developing reinforcement-based AI model for improvising the predictive skills of individuals with autism | Developing reinforcement-based AI model for improvising the predictive skills of individuals with autism | Govt Agency | 5,00,000/- | - | - |
| To evaluate the efficacy of oral probiotic supplementation in children with autism spectrum disorders (ASDs): A randomized double blind, placebo-controlled Trial | To evaluate the efficacy of oral probiotic supplementation in children with autism spectrum disorders (ASDs): A randomized double blind, placebo-controlled Trial | Govt Agency | 33,32,868/- | - | - |
| A Phase 3, Randomized, Double blind, Placebo-controlled efficacy and safety study of Ataluren in patients with non-sense mutation Duchenne Muscular Dystrophy and Open label extension | A Phase 3, Randomized, Double blind, Placebo-controlled efficacy and safety study of Ataluren in patients with non-sense mutation Duchenne Muscular Dystrophy and Open label extension | Private Agency | 50 lacs | - | - |
| Multi center Randomized double blind placebo-controlled trial to evaluate the effects of intra erythrocyte dexamethasone sodium phosphate on neurological symptoms in patients with Ataxia Telangiectasia | Multi center Randomized double blind placebo-controlled trial to evaluate the effects of intra erythrocyte dexamethasone sodium phosphate on neurological symptoms in patients with Ataxia Telangiectasia | Private Agency | 72 lacs | - | - |
| COMPASS: Communication-focused parent-mediated treatment for autism spectrum disorder in South Asia trial (University of Manchester and Sangath) | COMPASS: Communication-focused parent-mediated treatment for autism spectrum disorder in South Asia trial (University of Manchester and Sangath) | Private Agency | 11.2 cr | - | - |
| Establishment of Child Neurology Helpline and Tele-consultation services for Neurodevelopmental Disorders affecting infants, children, and adolescents from 1 month to 18 years of age - as a part of COE | Establishment of Child Neurology Helpline and Tele-consultation services for Neurodevelopmental Disorders affecting infants, children, and adolescents from 1 month to 18 years of age - as a part of COE | Govt Agency | 11.3 cr | - | - |
| Efficacy of Music therapy for treatment of Autism spectrum disorder in children and adolescents; a randomized controlled trial - as a part of COE | Efficacy of Music therapy for treatment of Autism spectrum disorder in children and adolescents; a randomized controlled trial - as a part of COE | Govt Agency | 11.3 cr | - | - |
| Efficacy of gluten and casein-free diet for treatment of Autism spectrum disorder in children and adolescents; a randomized controlled trial - as a part of COE | Efficacy of gluten and casein-free diet for treatment of Autism spectrum disorder in children and adolescents; a randomized controlled trial - as a part of COE | Govt Agency | 11.3 cr | - | - |
| Efficacy of ketogenic diet for treatment of electrographic nonconvulsive status epilepticus in infants, children, and adolescents - as a part of COE | Efficacy of ketogenic diet for treatment of electrographic nonconvulsive status epilepticus in infants, children, and adolescents - as a part of COE | Govt Agency | 11.3 cr | - | - |
| To develop textile- based and technology- based innovations for rehabilitation in children and adolescents aged 2 to 18 years with Autism spectrum Disorder and Cerebral Palsy - as a part of COE | To develop textile- based and technology- based innovations for rehabilitation in children and adolescents aged 2 to 18 years with Autism spectrum Disorder and Cerebral Palsy - as a part of COE | Govt Agency | 11.3 cr | - | - |
| Autism Spectrum Disorder in Indian infants, children, and adolescents; a clinical and exome sequencing-based study - as a part of COE | Autism Spectrum Disorder in Indian infants, children, and adolescents; a clinical and exome sequencing-based study - as a part of COE | Govt Agency | 11.3 cr | - | - |
| Epileptic encephalopathy in Indian infants, children, and adolescents; a clinical, electrophysiological, and exome sequencing-based study - as a part of COE | Epileptic encephalopathy in Indian infants, children, and adolescents; a clinical, electrophysiological, and exome sequencing-based study - as a part of COE | Govt Agency | 11.3 cr | - | - |
| Clinical and investigative profile in Indian infants, children, and adolescents with Muscular Dystrophy; a Muscle MRI, Skin biopsy, and exome sequencing-based study - as a part of COE | Clinical and investigative profile in Indian infants, children, and adolescents with Muscular Dystrophy; a Muscle MRI, Skin biopsy, and exome sequencing-based study - as a part of COE | Govt Agency | 11.3 cr | - | - |
| Etiological profile for acute/subacute/chronic encephalopathy/encephalitis syndrome affecting infants, children and adolescents (1 month - 18 years)- as a part of COE | Etiological profile for acute/subacute/chronic encephalopathy/encephalitis syndrome affecting infants, children and adolescents (1 month - 18 years)- as a part of COE | Govt Agency | 11.3 cr | - | - |
| National Knowledge, Resource and Training Centre for Neurodevelopmental Disorders affecting infants, children and adolescents (1 month - 18 years) - as a part of COE | National Knowledge, Resource and Training Centre for Neurodevelopmental Disorders affecting infants, children and adolescents (1 month - 18 years) - as a part of COE | Govt Agency | 11.3 cr | - | - |
| National Registry for Neurodevelopmental Disorders affecting infants, children and adolescents (1 month - 18 years) – as a part of COE | National Registry for Neurodevelopmental Disorders affecting infants, children and adolescents (1 month - 18 years) – as a part of COE | Govt Agency | 11.3 cr | - | - |